"Polycythemia vera" trang 1 - tải miễn phí từ tailieuXANH
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 1)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 1)

5    50    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 2)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 2)

5    51    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 3)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 3)

5    60    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 4)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 4)

5    47    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 5)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 5)

5    51    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 6)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 6)

5    40    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 7)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 7)

5    38    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 8)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 8)

5    38    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 9)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 9)
5    50    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 10)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 10)
8    35    0
Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)

Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)
7    42    0
Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018

Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
15    99    0
Cytoreductive treatment patterns among US veterans with polycythemia vera

Cytoreductive treatment patterns among US veterans with polycythemia vera
7    56    0
Gene expressions involved in immune system control and serum CA125 content in polycythemia vera

Gene expressions involved in immune system control and serum CA125 content in polycythemia vera
10    59    0
A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: A case report

A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: A case report
6    47    0
Báo cáo y học:

Báo cáo y học: " Polycythemia vera as a presentation of renal angiomyolipoma: a case report"
3    38    0
báo cáo hóa học:

báo cáo hóa học:" Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a"
17    39    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases
17    45    0
Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: Results from the living with MPNs survey

Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: Results from the living with MPNs survey
9    60    0
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
9    55    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.